Cargando…

Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion

AIM: To describe a case series of thyrotoxicosis likely triggered by SARS-CoV-2 vaccination and to warn physicians about this potential correlation. To report clinical, laboratory and imaging findings and provide further information that goes in line with the underlying mechanisms. METHODS: Single-c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pla Peris, B., Merchante Alfaro, A. Á., Maravall Royo, F. J., Abellán Galiana, P., Pérez Naranjo, S., González Boillos, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749352/ https://www.ncbi.nlm.nih.gov/pubmed/35015288 http://dx.doi.org/10.1007/s40618-022-01739-0

Ejemplares similares

Thymic Hyperplasia and Graves Disease: A Nonincidental Association
por: Pla Peris, Begoña, et al.
Publicado: (2023)

Case series of four re-infections with a SARS-CoV-2 B.1.351 variant, Luxembourg, February 2021
por: Staub, Thérèse, et al.
Publicado: (2021)

Thyroid as a target of adjuvant autoimmunity/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves’ disease to silent thyroiditis
por: Pujol, A., et al.
Publicado: (2021)

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study
por: Naranbhai, Vivek, et al.
Publicado: (2022)

3′-UTR of the SARS-CoV-2 genome as a possible source of piRNAs
por: Hernández-Huerta, María Teresa, et al.
Publicado: (2022)

The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus
por: Liu, Ying, et al.
Publicado: (2021)

Bivalent mRNA-1273.214 vaccine effectiveness against SARS-CoV-2 omicron XBB(*) infections
por: Chemaitelly, Hiam, et al.
Publicado: (2023)

Graves’ Thyrotoxicosis Following SARS-CoV-2 Infection
por: Harris, Asaf, et al.
Publicado: (2020)

Hemolysis induced by SARS-CoV-2 mRNA vaccination in patients with paroxysmal nocturnal hemoglobinuria
por: Kamura, Yuya, et al.
Publicado: (2022)

Pitfalls in SARS‐CoV‐2 PCR diagnostics
por: Wernike, Kerstin, et al.
Publicado: (2020)

SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction?
por: Tanda, M. L., et al.
Publicado: (2022)

Interaction of piRNA-like sequences from the 3′-UTR of SARS-CoV-2 with mRNA regions
por: Pérez-Campos Mayoral, Laura, et al.
Publicado: (2023)

Effects of BA.1/BA.2 subvariant, vaccination and prior infection on infectiousness of SARS-CoV-2 omicron infections
por: Qassim, Suelen H, et al.
Publicado: (2022)

The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant
por: Hodgson, David, et al.
Publicado: (2021)

Temporal signal and the phylodynamic threshold of SARS-CoV-2
por: Duchene, Sebastian, et al.
Publicado: (2020)

Emerging phylogenetic structure of the SARS-CoV-2 pandemic
por: Fountain-Jones, Nicholas M, et al.
Publicado: (2020)

Intra-genome variability in the dinucleotide composition of SARS-CoV-2
por: Digard, Paul, et al.
Publicado: (2020)

Alternate primers for whole-genome SARS-CoV-2 sequencing
por: Cotten, Matthew, et al.
Publicado: (2021)

Outcomes in Patients with SARS-CoV-2 and Clostridioides difficile Coinfection
por: Sehgal, Kanika, et al.
Publicado: (2021)

Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants
por: Zheng, Qianqian, et al.
Publicado: (2022)

Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021
por: Shitrit, Pnina, et al.
Publicado: (2021)

The SARS-CoV-2 Lambda variant and its neutralisation efficiency following vaccination with Comirnaty, Israel, April to June 2021
por: Zuckerman, Neta, et al.
Publicado: (2021)

Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021
por: Martínez-Baz, Iván, et al.
Publicado: (2021)

Isolated thrombosis after COVID-19 vaccination: case series
por: Al-Ahmad, Mona, et al.
Publicado: (2022)

Lineage BA.2 dominated the Omicron SARS-CoV-2 epidemic wave in the Philippines
por: Li, Yao-Tsun, et al.
Publicado: (2022)

Thyrotoxicosis
por: Short, A. Rendle
Publicado: (1941)

SARS‐CoV‐2 asymptomatic and symptomatic patients and risk for transfusion transmission
por: Corman, Victor M., et al.
Publicado: (2020)

Multivariate analyses of codon usage of SARS-CoV-2 and other betacoronaviruses
por: Gu, Haogao, et al.
Publicado: (2020)

Intra-host evolution during SARS-CoV-2 prolonged infection
por: Voloch, Carolina M, et al.
Publicado: (2021)

Antimicrobial silver nanoparticle-photodeposited fabrics for SARS-CoV-2 destruction
por: Kumar, Aditya, et al.
Publicado: (2021)

Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022
por: Huiberts, Anne J, et al.
Publicado: (2023)

SARS-CoV-2 infection in farmed minks, the Netherlands, April and May 2020
por: Oreshkova, Nadia, et al.
Publicado: (2020)

Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation
por: Charre, Caroline, et al.
Publicado: (2020)

An emergent clade of SARS-CoV-2 linked to returned travellers from Iran
por: Eden, John-Sebastian, et al.
Publicado: (2020)

Multi‐species ELISA for the detection of antibodies against SARS‐CoV‐2 in animals
por: Wernike, Kerstin, et al.
Publicado: (2020)

First cases of SARS-CoV-2 BA.2.86 in Denmark, 2023
por: Rasmussen, Morten, et al.
Publicado: (2023)

Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab
por: Paoli, D., et al.
Publicado: (2020)

Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020
por: Bogogiannidou, Zacharoula, et al.
Publicado: (2020)

Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021
por: Jungnick, Sabrina, et al.
Publicado: (2021)

Vaccine breakthrough infection and onward transmission of SARS-CoV-2 Beta (B.1.351) variant, Bavaria, Germany, February to March 2021
por: Kroidl, Inge, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hck0fgat4n7r9igmbjavo68ie7